Medtronic has announced that it has acquired combination product specialist Tyrx (Monmouth Junction, NJ) for $160 million. Tyrx, a spin-off from Rutgers University, was launched in 1998 to develop products to combat surgical-site infections ...
The U.S. Food and Drug Administration has approved the first device aimed at easing the pain of migraines preceded by aura -- sensory disturbances that occur just before an attack. About a third of migraine sufferers experience auras. ...
Tags: magnet device, pain of migraines, aura
The first device to treat migraine pain when the headache is preceded by an often-visual disturbance called an aura has been approved by the U.S. Food and Drug Administration. The Cerena Transcranial Magnetic Stimulator (TMS) is held to ...
The U.S. Food and Drug Administration has allowed marketing of the Cerena Transcranial Magnetic Stimulator, a device to relieve pain caused by migraines. Christy Foreman, director of the Office of Device Evaluation in the FDA's Center for ...
The Micra device is billed as the world's smallest pacemaker Medtronic is moving forward with studies on its own leadless pacemaker, the horse pill-sized Micra Transcatheter Pacing System that is only one-tenth the size of a standard ...
US-based Medtronic has announced that its Micra transcatheter pacing system (TPS) has been implanted in the first patient in Austria as part of the company’s multi-center global clinical trial. The single-arm, pivotal clinical trial ...
Medtronic's latest iteration of its Activa neurostimulator is not just a therapy device, but a brain activity information recorder that could provide insights into such devastating neurological disorders as Parkinson's disease. The first ...
Tags: health, Medtronic, neurostimulator, neurological disorders, Parkinson
Siemens Healthcare will introduce a new angiography system optimized for broad clinical utilization at the 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), 1 December through December 6 2013 ...
Biotronik, a manufacturer of cardiovascular medical devices, has obtained the US Food and Drug Administration (FDA) approval for Phase B of the company’s ongoing ProMRI clinical trial. Biotronik has recently completed Phase A of the ...
Tags: Promri Clinical Trial, Biotronik
Medtronic is touting a potential advance in the cardiovascular space: a recent study that shows some of the smarter algorithms it is using in its pacemakers actually slow the development of atrial fibrillation. The MINERVA study, ...
Tags: Pacemakers, Slow Heart, Rhythm Disorder
St. Jude Medical, a global medical device company, has completed the acquisition of Nanostim, a developer of miniaturized, leadless pacemakers. St. Jude Medical and Nanostim have entered into a series of agreements in May 2011, pursuant ...
Tags: St.Jude Medical, medical device
Respicardia, a US-based developer of implantable therapies, has announced the enrollment of the first patients in the pivotal trial to evaluate the remede system in patients with central sleep apnea (CSA). The Respicardia pivotal trial is ...
Tags: Respicardia, Patient Enrollment
This week Lenzing AG is celebrating the 75th anniversary of its business operations together with 3,000 invited guests – employees, customers, business companions, politicians and partners. The company presented the book “75 ...
Tags: Textile, Austria, fiber technology
Medtronic's study has demonstrated that simultaneously pacing the lower chambers of the heart, or biventricular (BiV) pacing with a cardiac resynchronization therapy (CRT) device, significantly improves heart failure symptoms and quality of ...
Tags: CRT Device, Heart Failure Symptoms
Wipro's global information technology, consulting and outsourcing business Wipro Technologies in collaboration with Microsoft has introduced Wipro AssureHealth platform to offer healthcare providers with new solutions for remote fetal ...
Tags: Wipro, Wipro Technologies, Microsoft